Kidney Disease News and Research

RSS

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Sickle cell trait increases risk of blood clots across diverse ancestries

National Institutes of Health (NIH) researchers and collaborators have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of blood clots, a risk that is the same among diverse human populations that may not traditionally be associated with sickle cell disease.

12 Sep 2024

Atrial fibrillation affects more Americans than previously estimated

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5% of the population, or 10.5 million U.S. adults, according to new estimates from UC San Francisco.

11 Sep 2024

Addressing the challenges of polycystic kidney disease

Polycystic kidney disease (PKD) is an intractable disorder that causes fluid-filled cysts to grow in the kidneys. It is typically seen in adults. As one of the most prevalent hereditary kidney diseases, the autosomal dominant form of PKD is usually caused by mutations in the PKD1 and PKD2 genes.

11 Sep 2024

Study finds link between nighttime light exposure and increased Alzheimer's disease risk

Higher nighttime light intensity is correlated with increased Alzheimer's disease prevalence, suggesting light pollution may influence neurodegenerative risks.

10 Sep 2024

Good heart health during early pregnancy may reduce genetic risk of preeclampsia and hypertension

Maintaining good cardiovascular health during the first trimester of pregnancy may offset the genetic risk of developing preeclampsia and/or gestational hypertension, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2024.

9 Sep 2024

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Researchers evaluate whether ultra-processed food and Mediterranean diet scores were associated with frailty and cardiometabolic disease in older adults.

6 Sep 2024

Study finds correlation between light pollution and Alzheimer's Disease

In some places around the globe, the lights never go off. Streetlights, roadway lighting, and illuminated signs can deter crime, make roads safer, and enhance landscaping. Undisrupted light, however, comes with ecological, behavioral, and health consequences.

6 Sep 2024

Weight-loss surgery offers better control of high blood pressure compared to medications

People with obesity who underwent weight-loss surgery were more likely to control their high blood pressure over a 1-to-5 year follow-period compared to those who managed their high blood pressure with medications and lifestyle management, according to preliminary research to be presented at the American Heart Association's Hypertension Scientific Sessions 2024.

5 Sep 2024

Many at-home blood pressure monitors may not fit most U.S. adults

At-home blood-pressure monitor cuffs may improperly fit many adults in the U.S., according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2024 and simultaneously published today in the journal Hypertension.

5 Sep 2024

Breakthrough research identifies key microenvironments linked to kidney injury and disease

A study published in Nature Communications provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI.

5 Sep 2024

New studies highlight elevated blood pressure and unmet social needs in young adults, children

Two separate studies show that elevated blood pressure and unmet social needs are a concern for young adults and children in the U.S. Both studies are preliminary research abstracts presented at the American Heart Association's Hypertension Scientific Sessions 2024.

5 Sep 2024

New program helps 74% of patients achieve blood pressure control

Up to 74% of adults with treatment-resistant high blood pressure were able to get their blood pressure below 140/90 mm HG within one year through a program combining remote blood pressure monitoring with pharmacist interactions, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2024.

5 Sep 2024

Akebia Therapeutics to present at upcoming investor conferences

Akebia Therapeutics®, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will participate in two investor conferences in September: Wells Fargo Healthcare Conference on September 4-6, 2024 in Boston and H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024 in New York.

From Akebia Therapeutics 4 Sep 2024

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

1 Sep 2024

Semaglutide's impact on cardiovascular health expands beyond weight loss

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19 related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC, the flagship journal of the American College of Cardiology.

30 Aug 2024

New ESC guidelines introduce intensive blood pressure targets and renal denervation recommendations

Updated ESC Guidelines on the management of elevated blood pressure and hypertension include a new elevated blood pressure category, more ambitious and intensive treatment targets, and, for the first time, recommendations on the use of renal denervation to treat various forms of hypertension.

30 Aug 2024

Major surgery complications unaffected by use of renin-angiotensin system inhibitors

There was no difference in major post-operative complications in patients who continued vs. stopped renin-angiotensin system inhibitors (RASIs) before non-cardiac surgery, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

30 Aug 2024

New smart mask monitors breath for real-time health analysis

Personalized wearable devices that monitor people's health are on the rise. From watches to patches and other types of sensors, these smart devices can monitor heart activity, inflammation levels, and more to help patients better manage their health from their own homes.

29 Aug 2024

Kidney Disease News and Research

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Sickle cell trait increases risk of blood clots across diverse ancestries

Atrial fibrillation affects more Americans than previously estimated

Addressing the challenges of polycystic kidney disease

Study finds link between nighttime light exposure and increased Alzheimer's disease risk

Good heart health during early pregnancy may reduce genetic risk of preeclampsia and hypertension

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Study finds correlation between light pollution and Alzheimer's Disease

Weight-loss surgery offers better control of high blood pressure compared to medications

Many at-home blood pressure monitors may not fit most U.S. adults

Breakthrough research identifies key microenvironments linked to kidney injury and disease

New studies highlight elevated blood pressure and unmet social needs in young adults, children

New program helps 74% of patients achieve blood pressure control

Akebia Therapeutics to present at upcoming investor conferences

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

Semaglutide's impact on cardiovascular health expands beyond weight loss

New ESC guidelines introduce intensive blood pressure targets and renal denervation recommendations

Major surgery complications unaffected by use of renin-angiotensin system inhibitors

New smart mask monitors breath for real-time health analysis

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News